Debt Limit Debate Weighs Down Markets
The debate over the debt limit weighed the markets down to a lower open with the Dow losing 36 points to 13,471. Nasdaq fell 21 points to 3096.
On the upside
The New York Stock Exchange granted Chimera (NYSE: CIM) an additional 30-day extension for continued listing.
The Food and Drug Administration approved Santarus' (Nasdaq: SNTS) ulcerative colitis treatment Uceris.
On the downside
Majesco Entertainment (Nasdaq: COOL) reported a loss for the fourth quarter despite higher revenue and warned of lower sales in 2013. Lululemon Athletica (Nasdaq: LULU) forecast fourth quarter revenue below analyst expectations.
SAP (NYSE: SAP) reported preliminary fourth quarter earnings and revenue that fell short of estimates.
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 index lost 5 points to 1465.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here